PVI, PeerView Institute for Medical Education

What an incredible turnout tonight at #SNO2024! A packed room of engaged attendees eager to learn about the latest advancements in #IDH-mutant #glioma care. Thank you to everyone who joined us and made this event a tremendous success! ?? A heartfelt thank you to Drs. Manmeet Ahluwalia, MD, MBA, FASCO, and Patrick Wen for leading such an exceptional symposium. Your expertise in targeted therapies and biomarker testing is invaluable in advancing patient care and improving outcomes. Special thanks to the American Brain Tumor Association (ABTA) for collaborating with us on this impactful program.

#Glioma updates from #SNO led by Drs. Ahluwalia - bit.ly/2024GliomaL

?? Today is #WorldPancreaticCancerDay, a day to stand together in raising awareness and supporting those affected by this challenging disease. Pancreatic cancer is often detected late, making early awareness and research critical. Join PVI, PeerView Institute for Medical Education, in honoring patients, survivors, and their families while also recognizing the healthcare professionals and researchers tirelessly working toward better treatments and outcomes. Together, we can shine a light on the fight against #pancreaticcancer and make a difference. #WorldPancreaticCancerDay #PancreaticCancerAwareness #WPCD

Innovation in prostate cancer treatment has brought advances to patients throughout the disease continuum, from localized disease and high-risk biochemical recurrence through mHSPC and mCRPC. Additionally, novel treatments such as hormonal therapies, PARP inhibitors, and radioligands used in monotherapy and combination regimens are setting new standards of care and improving patient outcomes. Register now to join PeerView Live, in partnership with ZERO Prostate Cancer, during the 2024 Society for Urologic Oncology Annual Meeting for a Clinical Consults session focused on patient-centric approaches for prostate cancer care. Through discussion of real-world cases, the expert faculty panel led by Neal Shore, MD, FACS, will link evidence supporting the efficacy and safety of a variety of treatment regimens with strategies for incorporating modern therapeutic approaches into individualized prostate cancer care across the disease spectrum. Topics will include identification of biochemical recurrence, implementation of genetic testing, team-based management of adverse events, and patient education strategies to optimize treatment adherence. Join the experts in person at #SUO24 or online on Friday, December 6, at 12:00 PM CST/1:00 PM EST to get a roadmap for navigating patient-centric prostate cancer care; https://bit.ly/24ProstateL #MedEd #UroOnc #Urology #Oncology This activity is supported by independent educational grants from Astellas Pharma and Pfizer Inc., Bayer HealthCare Pharmaceuticals Inc., The Janssen Pharmaceutical Companies of Johnson & Johnson, and Novartis Pharmaceuticals Corporation.

Join Us for a Prostate Cancer Clinical Consult at #SUO24! Led by Dr. Neal Shore and featuring Drs. Gordon A. Brown & Tanya Barauskas Dorff, this session will provide expert insights on developing patient-centered treatment plans using the latest clinical and real-world evidence. ?? Friday, December 6, 12:00 PM CST ?? In-person at #SUO24 or online at 12:15 PM CST / 1:15 PM EST In partnership with ZERO Prostate Cancer. Don’t miss it—register now!

Explore the Latest on Cardiac Myosin Inhibition! Join Milind Desai MD MBA and Anjali Owens for an expert discussion on CMIs, featuring real-world insights and practical guidance. Engage with the experts as they answer your questions in real-time during a live chat. Don’t miss this opportunity—join PeerView Live and The Mended Hearts, Inc. virtually on December 12 or January 9 at 7:00 PM EST!

Join Drs. Michelle Kittleson and Senthil Selvaraj on Dec 3 or Jan 7 at 7 PM EST for an engaging #ATTRCA #MedEd event, featuring expert insights and a live Q&A session. Don’t miss this opportunity to connect with leading voices in the field! #HFSA2024

Join Vanita Aroda, MD, on December 3, 5, or 12 for an engaging #T2D #MedEd Live Virtual Workshop. Submit your questions in advance and come prepared with challenging case examples for the last 30-minute office hours discussion!

#TGCT updates following #CTOS2024 led by William D. Tap - bit.ly/TGCT24L

Timely intensification of therapy is a foundational principle of contemporary management of type 2 diabetes (#T2D) to achieve optimal long-term outcomes. Evidence-based guidelines recommend treatment intensification if glycemic goals are not achieved within three months. However, fewer than 50% of people with T2D (PwT2D) receive this guideline-directed care. Weight loss, in addition to diabetes treatment intensification, has been shown to significantly improve outcomes, yet adequate weight loss is rarely achieved, and its benefits are frequently underestimated. As primary care professionals, where do we go next to improve our management of PwT2D? In the second in a series of three virtual workshops, collectively “The Office Hours Initiative,” Vanita R. Aroda, MD, will explore practical steps to overcome clinical inertia in the primary care setting. Learn the importance of intensifying T2D treatment to improve patient outcomes and the steps for selecting an appropriate treatment intensification strategy. You’ll also hear expert opinions and have a chance to discuss your challenging case examples. Register now for this cutting-edge event on T2D and weight management! Offered on December 3, 5, or 12. Submit your questions now and come prepared with challenging case questions for the office hours discussion in the last 30 minutes! https://bit.ly/T2DM-GL-F #MedEd #PrimaryCare